ESH-iCMLf 13th International Conference CHRONIC MYELOID LEUKEMIA - Biology and Therapy
Webcasted Presentation

Search’n Build™

Updated phase 1 data on ponatinib, a pan-BCR-ABL inhibitor, in CML and other hematologic malignancies

Jorge Cortes
Jorge Cortes
United States of America  
22 slide(s) – 00:14:53 – English – 2011-09-22
Extra Features Available

VIDEO PODCAST
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.